Uncurtaining the effect of COVID-19 in diabetes mellitus: a complex clinical management approach

Abstract

The aim of the present review is to overview the common properties of corona virus and hence proofs well beginning of corona virus in persons with diabetes, and its treatment. Globally, it has been observed that according to the statistics, India has the second largest number of people with diabetes. Literature review has been implemented within the databases using suitable keywords. For persons suffering from diabetic disorder, the COVID-19 infection becomes a dual challenge. Diabetes is a severe metabolic situation which causes the sugar levels in the blood to increase than the normal level. Normally, communicable disease like COVID-19 is more prevailing in patients with diabetes. Diabetic patient has poor immune response to infections. The different bacterial, viral, parasitic, and mycotic infections showed increased probability in diabetic patients as compared to non-diabetic patient. All these conclusions clear out the intention that the diabetic patients are more susceptible to enhanced inflammatory response that may lead to rapid spreading of COVID-19 infection with high rate of mortality. In the present situation of pandemic, managing diabetes seems to be quite challenging and diabetic patient having COVID-19 infection should follow normal course of antihypertensive and antidiabetic drugs prescribed with the exception of sodium glucose co-transpoters-2 inhibitors which would increase the risk of dehydration and ketoacidosis. In view of above discussion, this article highlights the proposed mechanism of COVID-19 infection linking it with diabetes, antidiabetic drugs to be used in COVID-19 infection along with their advantages, and disadvantages and management of COVID-19 infection diabetic patient.

Influencing factors of hospital-acquired COVID-19 prevention and control status among emergency support frontline healthcare workers under closed-loop management: a cross-sectional study

“…Reportedly, 17.14% (18/105) of medical staff were serologically 16), the risk of ESFHCWs' exposure to SARS-CoV-2 could be effectively reduced. One doctor was infected only 1 day after work, which may be related to the fact that he had type II diabetes and did not receive the third dose of a COVID-19 vaccine (17)(18)(19)(20). Also, in our study, we found that the total score of infection prevention and control status of nurses was higher than that of doctors, and the difference was statistically significant, suggesting that the infection prevention and control status of doctors should be improved.…”

Key Factors Fuelling India's Second COVID Surge

“…[25] With an unfavourable support system against this public health threat, diabetic patients having COVID-19 infection should follow normal course of antihypertensive and antidiabetic drugs prescribed with the exception of sodium glucose cotransporter-2 inhibitors which may increase the risk of dehydration and ketoacidosis. [26] A cornerstone of management of type 2 diabetes mellitus includes optimum weight management [27] and regular physical activity. [28] Physically active (PA) people have less severe symptoms, shorter recovery times, and are less likely to infect others, besides developing better immunity after an anticipated vaccination and minimize future complications.…”

The pandemic’s unseen wounds: COVID-19’s profound effects on mental health

“…In December 2019, a series of acute and atypical respiratory diseases was identified in Wuhan, China. The source of the illnesses was attributed to a novel coronavirus, named the SARS-CoV-2, and the subsequent disease it caused was named the COVID-19, and on 11 March 2020 it was declared a pandemic by the WHO 2 , 3 .…”